Serina Therapeutics Inc (SER)
NYSEAMERICAN: SER · IEX Real-Time Price · USD
9.71
+0.87 (9.84%)
At close: Jul 19, 2024, 4:00 PM
9.66
-0.05 (-0.51%)
After-hours: Jul 20, 2024, 12:58 PM EDT
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $81.70 million as of July 22, 2024. Its market cap has increased by 186.66% in one year.
Market Cap
81.70M
Enterprise Value
84.03M
1-Year Change
186.66%
Ranking
Category
Stock Price
Market Cap Chart
Since November 29, 2018, Serina Therapeutics's market cap has decreased from $97.10M to $81.70M, a decrease of -15.86%. That is a compound annual growth rate of -3.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 81.70M | 459.59% |
| Dec 29, 2023 | 14.60M | -30.14% |
| Dec 30, 2022 | 20.90M | -49.52% |
| Dec 31, 2021 | 41.40M | -27.75% |
| Dec 31, 2020 | 57.30M | -16.35% |
| Dec 31, 2019 | 68.50M | -36.04% |
| Dec 31, 2018 | 107.10M | 10.30% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AN2 Therapeutics | 83.22M |
| Sangamo Therapeutics | 82.40M |
| Instil Bio | 82.27M |
| Genenta Science | 82.16M |
| BioAtla | 81.80M |
| DBV Technologies | 80.83M |
| Chimerix | 80.66M |
| Protalix BioTherapeutics | 80.65M |